|
1
|
Becker HC and Mulholland PJ: Neurochemical
mechanisms of alcohol withdrawal. Handb Clin Neurol. 125:133–156.
2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mowbray O, Quinn A and Cranford JA: Social
networks and alcohol use disorders: Findings from a nationally
representative sample. Am J Drug Alcohol Abuse. 40:181–186.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Newton-Howes G and Foulds J: Personality
disorder and alcohol use disorder: An overview. Psychopathology.
51:130–136. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gilpin NW and Weiner JL: Neurobiology of
comorbid post-traumatic stress disorder and alcohol-use disorder.
Genes Brain Behav. 16:15–43. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Boulze-Launay I and Rigaud A: Alcohol and
loneliness: In my solitude. Int Forum Psychoanal. 29:65–73.
2020.
|
|
6
|
Brown ES, Carmody TJ, Schmitz JM, Caetano
R, Adinoff B, Swann AC and Rush AJ: A randomized, double-blind,
placebo-controlled pilot study of naltrexone in outpatients with
bipolar disorder and alcohol dependence. Alcohol Clin Exp Res.
33:1863–1869. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tawa EA, Hall SD and Lohoff FW: Overview
of the genetics of alcohol use disorder. Alcohol Alcohol.
51:507–514. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hasin DS, Stinson FS, Ogburn E and Grant
BF: Prevalence, correlates, disability, and comorbidity of DSM-IV
alcohol abuse and dependence in the United States: Results from the
national epidemiologic survey on alcohol and related conditions.
Arch Gen Psychiatry. 64:830–842. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yoon YH and Chen CM: Surveillance report
#105: Liver cirrhosis mortality in the United States: National,
state, and regional trends, 2000-2013. Bethesda, MD, National
Institute on Alcohol Abuse and Alcoholism (NIAAA), 2016. Available
from: http://pubs.niaaa.nih.gov/publications/Surveillance105/Cirr13.pdf.
|
|
10
|
Schuckit MA: Recognition and management of
withdrawal delirium (delirium tremens). N Engl J Med.
371:2109–2113. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Muncie HL Jr, Yasinian Y and Oge' L:
Outpatient management of alcohol withdrawal syndrome. Am Fam
Physician. 88:589–595. 2013.PubMed/NCBI
|
|
12
|
World Health Organization: Status report
on alcohol consumption, harm and policy responses in 30 European
countries. Copenhaga, WHO, 2019.
|
|
13
|
Iovu MB and Breaz MA: The prevalence and
burden of mental and substance use disorders in romania: findings
from the global burden of disease study 2016. Psychiatr Danub.
31:457–464. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ventura-Cots M, Watts AE and Bataller R:
Binge drinking as a risk factor for advanced alcoholic liver
disease. Liver Int. 37:1281–1283. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Trifu S, Marica S, Braileanu D, Carp EG
and Gutt AM: Teaching psychiatric concepts of neurosis, psychosis
and borderline pathology. Conceptual boundaries. Proc Soc Behav
Sci. 203:125–129. 2015.
|
|
16
|
Cederbaum AI: Alcohol metabolism. Clin
Liver Dis. 16:667–685. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Deitrich R, Zimatkin S and Pronko S:
Oxidation of ethanol in the brain and its consequences. Alcohol Res
Health. 29:266–273. 2006.PubMed/NCBI
|
|
18
|
The National Institute on Alcohol Abuse
and Alcoholism. Alcohol metabolism: An update. Alcohol Res Health.
72:1–5. 2007.
|
|
19
|
Wilson DF and Matschinsky FM: Ethanol
metabolism: The good, the bad, and the ugly. Med Hypotheses.
140(109638)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ceni E, Mello T and Galli A: Pathogenesis
of alcoholic liver disease: Role of oxidative metabolism. World J
Gastroenterol. 20:17756–17772. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Costea R, Zarnescu NO, Vasiliu EC, Minca
D, Sajin M and Neagu S: B1 versus B2 Dukes stage rectal cancer:
Prospective evaluation of 87 patients in a single institution and
quest for re-evaluation of the current proto.
Hepatogastroenterology. 59:98–100. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Volkow ND, Koob G and Baler R: Biomarkers
in substance use disorders. ACS Chem Neurosci. 6:522–525.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Trifu S, Carp EG and Nadoleanu A: Alcohol
as a substitute, mask of depression and ‘antidote’ of narcissism.
Eur Proc Soc Behav Sci. 31:986–994. 2017.
|
|
24
|
Cabral Barata P, Oliveira CFP, Lima de
Castro S and Rocha da Mota AMP: A systematic review on substance
addiction: Medical diagnosis or morality flaw? Eur J Psychiatry.
33:143–151. 2019.
|
|
25
|
Jung YC and Namkoong K: Alcohol:
Intoxication and poisoning-diagnosis and treatment. Handb Clin
Neurol. 125:115–121. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Long D, Long B and Koyfman A: The
emergency medicine management of severe alcohol withdrawal. Am J
Emerg Med. 35:1005–1011. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jesse S, Bråthen G, Ferrara M, Keindl M,
Ben-Menachem E, Tanasescu R, Brodtkorb E, Hillbom M, Leone MA and
Ludolph AC: Alcohol withdrawal syndrome: Mechanisms,
manifestations, and management. Acta Neurol Scand. 135:4–16.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kattimani S and Bharadwaj B: Clinical
management of alcohol withdrawal: A systematic review. Ind
Psychiatry J. 22:100–108. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Isenberg-Grzeda E, Kutner HE and Nicolson
SE: Wernicke-Korsakoff-syndrome: Under-recognized and
under-treated. Psychosomatics. 53:507–516. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Muzyk AJ, Leung JG, Nelson S, Embury ER
and Jones SR: The role of diazepam loading for the treatment of
alcohol withdrawal syndrome in hospitalized patients. Am J Addict.
22:113–118. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Perry EC: Inpatient management of acute
alcohol withdrawal syndrome. CNS Drugs. 28:401–410. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bautista AP: Liver injury during alcohol
use and withdrawal. In: Comprehensive Handbook of Alcohol Related
Pathology. Preedy VR and Watson RR (eds). Academic Press,
Cambridge, pp491-500, 2005.
|
|
33
|
Rodighiero V: Effects of liver disease on
pharmacokinetics. An update. Clin Pharmacokinet. 37:399–431.
1999.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Samokhvalov AV, Irving H, Mohapatra S and
Rehm J: Alcohol consumption, unprovoked seizures, and epilepsy: A
systematic review and meta-analysis. Epilepsia. 51:1177–1184.
2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Trifu S and Trifu AD: Receptor profiles of
atypical antipsychotic molecules. UPB Sci Bull. 82:113–128.
2020.
|
|
36
|
Frye GD and Fincher AS: Effect of ethanol
on gamma-vinyl GABA-induced GABA accumulation in the substantia
nigra and on synaptosomal GABA content in six rat brain regions.
Brain Res. 449:71–79. 1988.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tsai G and Coyle JT: The role of
glutamatergic neurotransmission in the pathophysiology of
alcoholism. Annu Rev Med. 49:173–184. 1998.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pinel JP and Van Oot PH: Generality of the
kindling phenomenon: Some clinical implications. Can J Neurol Sci.
2:467–475. 1975.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wojnar M, Bizoń Z and Wasilewski D:
Assessment of the role of kindling in the pathogenesis of alcohol
withdrawal seizures and delirium tremens. Alcohol Clin Exp Res.
23:204–208. 1999.PubMed/NCBI
|
|
40
|
Shaw GK: Detoxification: The use of
benzodiazepines. Alcohol Alcohol. 30:765–770. 1995.PubMed/NCBI
|
|
41
|
Delcò F, Tchambaz L, Schlienger R, Drewe J
and Krähenbühl S: Dose adjustment in patients with liver disease.
Drug Saf. 28:529–545. 2005.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Amarapurkar DN: Prescribing medications in
patients with decompensated liver cirrhosis. Int J Hepatol.
2011(519526)2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kraemer KL, Conigliaro J and Saitz R:
Managing alcohol withdrawal in the elderly. Drugs Aging.
14:409–425. 1999.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ramanujam R, Padma L, Swaminath G and
Thimmaiah RS: A comparative study of the clinical efficacy and
safety of lorazepam and chlordiazepoxide in alcohol dependence
syndrome. J Clin Diagn Res. 9:FC10–FC13. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Grønbæk L, Watson H, Vilstrup H and Jepsen
P: Benzodiazepines and risk for hepatic encephalopathy in patients
with cirrhosis and ascites. United European Gastroenterol J.
6:407–412. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ahboucha S and Butterworth RF: Role of
endogenous benzodiazepine ligands and their GABA-A-associated
receptors in hepatic encephalopathy. Metab Brain Dis. 20:425–437.
2005.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Vidaurre J, Gedela S and Yarosz S:
Antiepileptic drugs and liver disease. Pediatr Neurol. 77:23–36.
2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lynn E, Lyons S, Langan Y, Craig S and
Doherty C: The role of alcohol dependency in deaths among people
with epilepsy recorded by the national drug-related deaths index
(NDRDI) in Ireland, 2004-2013. Seizure. 45:52–55. 2017.PubMed/NCBI View Article : Google Scholar
|
